Search STAA
STAAR SURGICAL CO
Nasdaq · CIK 718937
Last close22.47
Daily change+0.09 (0.40%)
10 Years gain+139.30%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
STAA · STANDARD
SIC 3851 · Ophthalmic Goods · Fiscal year end 0102
Fundamental
34.6Momentum
100.0Acceleration
100.0Confidence
83.0Annual Revenue18
Quarterly Revenue89
Annual CFO16
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth3.4 / 25
Quality12.8 / 25
Capital Efficiency1.7 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Operating leverageOperating margin improved by 15.7156 percentage points.
ROIC expansionROIC improved by 23.6991 percentage points.
Warnings
Receivables anomaly · MEDIUMAccounts receivable growth is materially above revenue growth.
Key Metrics
Revenue Growth TTM6.04%OK
Revenue CAGR 3Y0%OK
Gross Margin76.43%OK
Operating Margin2.03%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC2.76%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y4.37%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Jan 02, 2026 | $239.44M | $182.42M | -$91.71M | -$34.23M | -$40.05M | 76.19% | -38.3% | -16.73% | -44.79% | 49.57M |
| 2025 FY Dec 27, 2024 | $313.90M | $239.58M | -$12.61M | $15.73M | -$7.67M | 76.32% | -4.02% | -2.44% | -6% | 49.13M |
| 2025 FY Dec 29, 2023 | $322.42M | $252.65M | $28.10M | $14.59M | -$3.59M | 78.36% | 8.71% | -1.11% | n/a | 49.43M |
| 2024 FY Dec 30, 2022 | n/a | $223.38M | $43.80M | $35.72M | $17.61M | n/a | n/a | n/a | n/a | 49.38M |
| 2025 FY Dec 30, 2022 | $239.44M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $326.11M | sum latest 4 fiscal quarters Revenue | OK | 0000718937-26-000037, 0001193125-25-266879 |
| Revenue Growth TTM | 6.04% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0000718937-26-000037, 0001193125-25-266879 |
| Revenue CAGR 3Y | 0% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0000718937-26-000004 |
| Revenue CAGR 5Y | 61.12% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0000718937-26-000004 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0000718937-26-000004 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0000718937-26-000037, 0001193125-25-266879 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 76.43% | Gross Profit / Revenue | OK | 0000718937-26-000037, 0001193125-25-266879 |
| Operating Margin | 2.03% | Operating Income / Revenue | OK | 0000718937-26-000037, 0001193125-25-266879 |
| ROIC | 2.76% | NOPAT / Average Invested Capital | OK | 0000718937-26-000037, 0001193125-25-266879 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0000718937-26-000037 |
| Current Ratio | 4.66x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $6.33 | Revenue / Diluted Shares | OK | 0000718937-26-000037, 0001193125-25-266879 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |